Serum interleukin-17 as a diagnostic and prognostic marker for non-small cell lung cancer

Author： Xu Chunhua   Hao Keke   Yu Like   Zhang Xiuwei  

Publisher： Informa Healthcare

ISSN： 1366-5804

Source： Biomarkers, Vol.19, Iss.4, 2014-06, pp. : 287-290

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The development of immunotherapies for non-small cell lung cancer

By Salgaller Michael L  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 3, 2002-03 ,pp. : 265-278

Informa Healthcare

Access to resources Recommend Favorite

Cetuximab in non-small cell lung cancer

By Ademuyiwa Foluso O   Hanna Nasser  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 1, 2008-01 ,pp. : 107-113

Informa Healthcare

Access to resources Recommend Favorite

Prognostic value of S-100 immunostaining in tumour cells of non-small cell lung cancer

By Jassem E.   Serkies K.   Dziadziuszko R.   Drozdowska A.   Kobierska-Gulida G.   Skokowski J.   Góźdź S.   Urbaniak A.   Sygut J.   Jassem J.  

Biomarkers, Vol. 11, Iss. 3, 2006-05 ,pp. : 262-269

Informa Healthcare

Access to resources Recommend Favorite

Serum superoxide dismutase, a potential predictor for radiation pneumonitis following chemoradiotherapy in non-small cell lung cancer patients

By Wang Dongqing   Zhu Jingyu   Sun Mingping   Li Baosheng   Wei Ling   Wang Zhongtang   Sun Hongfu  

Biomarkers, Vol. 17, Iss. 5, 2012-08 ,pp. : 455-462

Informa Healthcare

Access to resources Recommend Favorite

The role of talactoferrin alfa in the treatment of non-small cell lung cancer

By Kelly Ronan J   Giaccone Giuseppe  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 9, 2010-09 ,pp. : 1379-1386

Informa Healthcare

Access to resources Recommend Favorite